Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study (Q36906089)

17 August 2017

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study (English)

1 reference

17 August 2017

0 references

10

Emmanuelle Waubant

1 reference

17 August 2017

Bianca Weinstock-Guttman

18

object named as

Bianca Weinstock-Guttman

1 reference

17 August 2017

4

Raymond Tellier

1 reference

17 August 2017

Olga Bykova

9

0 references

Martino Ruggieri

object named as

Martino Ruggieri

15

0 references

Amit Bar-or

27

object named as

Amit Bar-Or

1 reference

17 August 2017

Brenda Banwell

1

1 reference

17 August 2017

Lauren Krupp

2

1 reference

17 August 2017

Julia Kennedy

3

1 reference

17 August 2017

Silvia Tenembaum

5

1 reference

17 August 2017

Jayne Ness

6

1 reference

17 August 2017

Anita Belman

7

1 reference

17 August 2017

Alexei Boiko

8

1 reference

17 August 2017

Jean K Mah

11

1 reference

17 August 2017

Cristina Stoian

12

1 reference

17 August 2017

Marcelo Kremenchutzky

13

1 reference

17 August 2017

Maria Rita Bardini

14

1 reference

17 August 2017

Mary Rensel

16

1 reference

17 August 2017

Jin Hahn

17

1 reference

17 August 2017

E Ann Yeh

19

1 reference

17 August 2017

Kevin Farrell

20

1 reference

17 August 2017

Mark Freedman

21

1 reference

17 August 2017

Matti Iivanainen

22

1 reference

17 August 2017

Meri Sevon

23

1 reference

17 August 2017

Virender Bhan

24

1 reference

17 August 2017

Marie-Emmanuelle Dilenge

25

1 reference

17 August 2017

Derek Stephens

26

1 reference

17 August 2017

1 September 2007

1 reference

17 August 2017

1 reference

17 August 2017

6

1 reference

17 August 2017

9

1 reference

17 August 2017

773-781

1 reference

First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability.

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Prognostic factors for early severity in a childhood multiple sclerosis cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Multiple sclerosis in childhood: clinical features of 149 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Prospective study of multiple sclerosis with early onset

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Pediatric multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Course and prognosis in early-onset MS: comparison with adult-onset forms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Definite and suspected multiple sclerosis in children: long-term follow-up and magnetic resonance imaging findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Clinical characteristics and long term prognosis in early onset multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Pediatric multiple sclerosis report of 14 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Clinical course and prognosis of 27 patients with childhood onset multiple sclerosis in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

The worldwide prevalence of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Epstein-Barr virus and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Epstein-Barr virus and disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Multiple sclerosis is linked to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Epstein-Barr virus in pediatric multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

High seroprevalence of Epstein-Barr virus in children with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Consensus definitions proposed for pediatric multiple sclerosis and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Revised diagnostic criteria for neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Discrepancies in the interpretation of clinical symptoms and signs in the diagnosis of multiple sclerosis. A proposal for standardization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Risk factors for developing multiple sclerosis after childhood optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Proposed diagnostic criteria and nosology of acute transverse myelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Evolution, development and timing of puberty

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Key issues in the diagnosis and treatment of multiple sclerosis. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

The cognitive burden of multiple sclerosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Cognitive functioning in children and adolescents with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Interferon-beta treatment in patients with childhood-onset multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Interferon beta-1a in children with multiple sclerosis is well tolerated

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

The use of interferon beta in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Association between clinical disease activity and Epstein-Barr virus reactivation in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Cross reaction of antibodies to a glycine/alanine repeat sequence of Epstein-Barr virus nuclear antigen-1 with collagen, cytokeratin, and actin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Herpes simplex virus types 1 and 2 and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Exposure to infant siblings during early life and risk of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Infectious agents and multiple sclerosis--are Chlamydia pneumoniae and human herpes virus 6 involved?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

Chlamydia pneumoniae in children with MS: frequency and quantity of intrathecal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970196-5

7 January 2021

10.1016/S1474-4422(07)70196-5

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jvtxoyo4crectczpi7tm54kv2q

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_jvtxoyo4crectczpi7tm54kv2q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jvtxoyo4crectczpi7tm54kv2q

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/jvtxoyo4crectczpi7tm54kv2q

30 July 2022